Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae β-ketoacyl-acyl carrier protein synthase III (FabH)

被引:99
作者
Khandekar, SS
Gentry, DR
Van Aller, GS
Warren, P
Xiang, H
Silverman, C
Doyle, ML
Chambers, PA
Konstantinidis, AK
Brandt, M
Daines, RA
Lonsdale, JT
机构
[1] Glaxo SmithKline, Dept Prot Biochem, King Of Prussia, PA 19406 USA
[2] Glaxo SmithKline, Dept Prot Biochem, King Of Prussia, PA 19406 USA
[3] Glaxo SmithKline, Dept Biol Struct, King Of Prussia, PA 19406 USA
[4] Glaxo SmithKline, Dept Bioinformat, King Of Prussia, PA 19406 USA
[5] Glaxo SmithKline, Dept Mechanist Enzymol, King Of Prussia, PA 19406 USA
[6] Glaxo SmithKline, Dept Med Chem, King Of Prussia, PA 19406 USA
[7] Glaxo SmithKline, Dept Microbial Biochem, King Of Prussia, PA 19406 USA
关键词
D O I
10.1074/jbc.M101769200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the bacterial type II fatty acid synthase system, beta -ketoacyl-acyl carrier protein (ACP) synthase IH (FabH) catalyzes the condensation of acetyl-CoA with malonyl-ACP. We have identified, expressed, and characterized the Streptococcus pneumoniae homologue of Escherichia coli FabH. S. pneumoniae FabH is similar to 41, 39, and 38% identical in amino acid sequence to Bacillus subtilis, E. coli and Hemophilus influenzae FabH, respectively. The His-Asn-Cys catalytic triad present in other FabH molecules is conserved in S. pneumoniae FabH. The apparent K-m values for acetyl-CoA and malonyl-ACP were determined to be 40.3 and 18.6 muM, respectively. Purified S. pneumoniae FabH preferentially utilized straight short-chain CoA primers. Similar to E. coli FabH, S. pneumoniae FabH was weakly inhibited by thiolactomycin. In contrast, inhibition of S. pneumoniae FabH by the newly developed compound SB418011 was very potent, with an IC50 value of 0.016 muM. SB418011 also inhibited E. coli and H. influenzae FabH with IC50 values of 1.2 and. 0.59 muM, respectively. The availability of purified and characterized S. pneumoniae FabH will greatly aid in structural studies of this class of essential bacterial enzymes and. facilitate the identification of small molecule inhibitors of type II fatty acid synthase with the potential to be novel and potent antibacterial agents active against pathogenic bacteria.
引用
收藏
页码:30024 / 30030
页数:7
相关论文
共 36 条
[12]  
GARWIN JL, 1980, J BIOL CHEM, V255, P1949
[13]   Characterization of β-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis [J].
Han, L ;
Lobo, S ;
Reynolds, KA .
JOURNAL OF BACTERIOLOGY, 1998, 180 (17) :4481-4486
[14]   MECHANISM OF ACTION OF THE ANTIBIOTIC THIOLACTOMYCIN INHIBITION OF FATTY-ACID SYNTHESIS OF ESCHERICHIA-COLI [J].
HAYASHI, T ;
YAMAMOTO, O ;
SASAKI, H ;
KAWAGUCHI, A ;
OKAZAKI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 115 (03) :1108-1113
[15]   Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli [J].
Heath, RJ ;
Rock, CO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10996-11000
[16]   Crystal structure of β-ketoacyl-acyl carrier protein synthase II from E-coli reveals the molecular architecture of condensing enzymes [J].
Huang, WJ ;
Jia, J ;
Edwards, P ;
Dehesh, K ;
Schneider, G ;
Lindqvist, Y .
EMBO JOURNAL, 1998, 17 (05) :1183-1191
[17]  
JACKOWSKI S, 1989, J BIOL CHEM, V264, P7624
[18]  
JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927
[19]   HUMAN FATTY-ACID SYNTHASE - PROPERTIES AND MOLECULAR-CLONING [J].
JAYAKUMAR, A ;
TAI, MH ;
HUANG, WY ;
ALFEEL, W ;
HSU, M ;
ABUELHEIGA, L ;
CHIRALA, SS ;
WAKIL, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8695-8699
[20]   ISO-FATTY AND ANTEISO-FATTY ACIDS IN BACTERIA - BIOSYNTHESIS, FUNCTION, AND TAXONOMIC SIGNIFICANCE [J].
KANEDA, T .
MICROBIOLOGICAL REVIEWS, 1991, 55 (02) :288-302